Podcast Episodes
Back to SearchJan 18, 2019 This Week in Cardiology Podcast
Burnout, aspiration thrombectomy, fish intake, insurance coverage, and the gout drug febuxostat are discussed in this week's podcast.
7 years, 5 months ago
Jan 11, 2019 This Week in Cardiology Podcast
Appropriate use criteria for imaging, HRRP efficacy, medical marijuana, radiation exposure in the cath lab, and hormone therapy are the topics discus…
7 years, 5 months ago
Jan 4, 2019 This Week in Cardiology Podcast
The cost of treating high blood pressure, heart-failure readmission policies, abdominal fat, low flow/low gradient aortic stenosis and hypertensive d…
7 years, 5 months ago
Dec 21, 2018 This Week in Cardiology Podcast
Dr John Mandrola discusses upcoding for PCI, hypertension, a pacing lead issue, a PAD trial discovery, and an FDA warning on fluoroquinolones in this…
7 years, 6 months ago
Dec 14, 2018 This Week in Cardiology Podcast
Carotid stents, more stem-cell retractions, AHA statement on statin safety, flu vaccine rules, medication errors, veterans care, and wasteful NIH res…
7 years, 6 months ago
Dec 7, 2018 This Week in Cardiology Podcast
Measures of hospital quality, statin under- or over-use, Botox for AF, smoking cessation and translating trial evidence to clinical practice are disc…
7 years, 6 months ago
Nov 30, 2018 This Week in Cardiology Podcast
TAVR vs surgery for high-risk aortic stenosis, conflicts of interest for physicians and societies, spin in the CV literature, and low-carb diets are …
7 years, 6 months ago
Nov 16, 2018 This Week in Cardiology Podcast
The top 5 studies from the recent American Heart Association meeting and the new cholesterol guidelines are discussed in this week's podcast.
7 years, 7 months ago
Nov 9, 2018 This Week in Cardiology Podcast
ODYSSEY PCSK9 inhibitor trial in print, new bradycardia guidelines, echocardiography, and an AHA preview are the topics discussed in this week's podc…
7 years, 7 months ago
Nov 2, 2018 This Week in Cardiology Podcast
CV outcomes in patients with type 2 diabetes, canagliflozin, cardiorespiratory fitness, the value of randomized trials, and the most important paper …
7 years, 7 months ago